1. © Coherent market Insights. All Rights Reserved PARKINSON’S DISEASE THERAPEUTIC MARKET Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025 © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Parkinson’s disease (PD) is a chronic disorder characterized by the malfunctioning and death of vital nerve cells in the brain, and can be characterized by tremor, dementia, and depression. Parkinson’s disease progression leads to uncontrolled body movement of the patient. There is no cure presently for parkinson’s disease only treatments options such as medication and surgery to manage the symptoms are available. Parkinson’s disease mainly affects people over 50 and the risk increases with increasing age. Parkinson’s disease treatment is used to control symptoms such as uncontrolled movement, shakiness of hands, and some others. The therapeutic approaches like levodopa in combination with carbidopa is considered as an effective treatment over symptoms of Parkinson’s disease. The surgical treatment option is available but it is only effective for patients who are previously responded to levodopa therapy. The research and development in the field of Parkinson’s disease therapeutic will help in the treatment of Parkinson’s disease. Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/494 https://www.coherentmarketinsights.com/insight/request-sample/494 Increase in prevalence of Parkinson’s disease across the world is driving the Parkinson’s disease therapeutic market According to Parkinson’s disease foundation, more than 10 million people globally are living with Parkinson’s disease and 60,000 Americans are diagnosed with Parkinson’s disease each year. Automatic Cell Imaging System Market Overview

3. © Coherent market Insights. All Rights Reserved The rising prevalence of Parkinson’s disease across the world is one of the major factor which is driving the Parkinson’s disease therapeutic market. Rising male patients, is also the major factor owing to Parkinson’s disease therapeutic market, because as mentioned in the data of Parkinson’s disease foundation, chances of getting Parkinson’s disease are one and half times more in men than women. The increase in number of geriatric population and technological advancements such as combination therapies for prolong action of continuous dopaminergic stimulation drugs, gene therapy, neural transplantation are some other causes which are likely to drive the Parkinson’s disease therapeutic market. However some restraints like expiry of patents for several drugs such as Stalevo, Azilect, Rytary, Comtan etc. can cause the cessation of Parkinson’s disease therapeutic market. The advancements in medical devices segment for Parkinson’s disease treatment is expected to boost the growth in Parkinson’s disease therapeutic market Global Parkinson’s disease therapeutic market is segmented on the basis of treatment type, end user and geographical regions On the basis of treatment type, Medical Devices Deep Brain Stimulation (DBS) Devices Carbidopa/Levodopa Enteral Suspension (Duopa) delivery devices Drug Class Dopamine precursors Request a Customization: https://www.coherentmarketinsights.com/insight/request-customization/494 https://www.coherentmarketinsights.com/insight/request-customization/494 REPORT DESCRIPTION

4. © Coherent market Insights. All Rights Reserved REPORT DESCRIPTION New advancements in the treatment of parkinson’s disease has helped to boost the growth in North America for parkinson’s disease therapeutic market. Regional segmentation of Parkinson’s disease therapeutic market according to coherent market Insights comprises of North America, Latin America, Europe, Asia pacific, Middle East, and Africa. New product development is the key strategy adopted by major industry player in Parkinson’s disease therapeutic market Key players in the Parkinson’s disease therapeutics market globally are Salix Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline Plc., Mylan N.V., Orion Corporation, Boehringer Ingelheim, UCB, and Impax Labs. Many of the key players involved in the anti-Parkinson’s disease medication and some of the biopharmaceuticals research companies in the U.S. are currently in the development of new medicines for treatment of Parkinson’s disease. The industry players such as Novartis AG, Pfizer, Ceregene, and Biogen are expected to launch new drugs for Parkinson’s disease treatment in the future. Get Exclusive Discount on this CMI Report: https://www.coherentmarketinsights.com/insight/request-discount/494 https://www.coherentmarketinsights.com/insight/request-discount/494

5. © Coherent market Insights. All Rights Reserved Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. ABOUT US ABOUT COHERENT MARKET INSIGHTS SERVICES INDUSTRY ANALYSIS CUSTOMIZED RESEARCH SYNDICATED RESEARCH CONSULT STUDIES MARKET INTELLIGENCE SERVICES COUNTRY SPECIFIC STUDIES

6. © Coherent market Insights. All Rights Reserved  Global Leading Equipment and System Manufacturers  Component Providers and System Integrators  Distributors, Retailors and Value Added Resellers  Healthcare IT Solutions Developers  Marketing Consultancies and the Advertising Industry  Private and Government organization  Outsourcing Companies  Universities and Business Schools. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGYCLINICAL DIAGNOSTICHEALTHCARE IT PHARMACEUTICALMEDICAL IMAGINGMEDICAL DEVICES OUR CLIENTS

7. © Coherent market Insights. All Rights Reserved Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. ABOUT US RESEARCH SOLUTIONS GLOBAL REPORTS FEASIBILITY STUDIES TECHNOLOGY SNIPPETS EXCEL FORECAST DATABASE COMPETITIVE ASSESSMENT SURVEY RESEARCH CUSTOMIZED SOLUTIONS CONSULT PROJECTS COUNTRY ANALYSIS KEY STATS Insights Published Per Year Consulting Projects Till Date Clients Worldwide Per Year Analysts and Contract Consultants 100+ 150+ 125+ 110+

8. © Coherent market Insights. All Rights Reserved THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702